APA (7th ed.) Citation

DK, R., BJ, T., PT, T., CP, P., C, D., ME, A., . . . KJ, P. (2022). Interim analysis of companion, prospective, phase II, clinical trials assessing the efficacy and safety of multi-modal total eradication therapy in men with synchronous oligometastatic prostate cancer. Medical oncology (Northwood, London, England), 39(5), 63. https://doi.org/10.1007/s12032-022-01662-7

Chicago Style (17th ed.) Citation

DK, Reyes, et al. "Interim Analysis of Companion, Prospective, Phase II, Clinical Trials Assessing the Efficacy and Safety of Multi-modal Total Eradication Therapy in Men with Synchronous Oligometastatic Prostate Cancer." Medical Oncology (Northwood, London, England) 39, no. 5 (2022): 63. https://doi.org/10.1007/s12032-022-01662-7.

MLA (9th ed.) Citation

DK, Reyes, et al. "Interim Analysis of Companion, Prospective, Phase II, Clinical Trials Assessing the Efficacy and Safety of Multi-modal Total Eradication Therapy in Men with Synchronous Oligometastatic Prostate Cancer." Medical Oncology (Northwood, London, England), vol. 39, no. 5, 2022, p. 63, https://doi.org/10.1007/s12032-022-01662-7.